Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-14T06:27:23.155Z Has data issue: false hasContentIssue false

25 - Transcranial magnetic stimulation and deep brain stimulation

from Section 4 - Specific modalities of treatment

Published online by Cambridge University Press:  05 May 2013

By
Sarah H. Lisanby  and
Moacyr A. Rosa
Edited by
J. John Mann
Edited in association with
Patrick J. McGrath  and
Steven P. Roose
J. John Mann
Affiliation:
Columbia University, New York
Patrick J. McGrath
Affiliation:
Columbia University, New York
Steven P. Roose
Affiliation:
Columbia University, New York
Get access

Summary

This chapter reviews the basic principles of the clinical application of transcranial magnetic stimulation (TMS) for the treatment of major depression. In October 2008, TMS was approved by the Food and Drug Administration (FDA) in the USA for the treatment of adults with medication-resistant unipolar major depressive disorder (MDD) who have failed one adequate pharmacological trial. The World Federation of Societies of Biological Psychiatry's guidelines endorsed the International Society of Transcranial Stimulation (ISTS) guidelines concerning TMS administration. The original uses of TMS were in the study of the motor cortex and motor pathways, where there is a simple and objective way of measuring the effects of the stimulation in the motor system. The cortical area that has been the main target for the treatment of depression with TMS is the dorsolateral prefrontal cortex (DLPFC).

Keywords

premenstrual syndromemenopause transitionmenstrual cyclepremenstrual dysphoric disorderselective serotonin reuptake inhibitorsmajor depressive disorderfemale sex hormonesdepression
Type
Chapter
Information
Clinical Handbook for the Management of Mood Disorders , pp. 325 - 331
Publisher: Cambridge University Press
Print publication year: 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×